- Exhibit & Support
- Hotel & Travel
Biosimilars are projected to lower health care costs and deliver more therapeutic options for physicians and patients. This presentation provides an overview of key pharmacist-specific considerations for biosimilars, including details of the approval process, considerations for appropriate use, and practices that mitigate inadvertent substitution and encourage accurate adverse event reporting.
Speakers: Indu Lew, PharmD; Brad Jordan,PhD
Presented by Amgen Inc.